Art

J-GLOBAL ID：200902233656209751   Reference number：08A0404248

Risperidone内用液1mg/mLの使用成績調査-Risperidone内用液の安全性と服薬アドヒアランスの確保に向けて-

Author (6)： IYO MASAOMI (千葉大 大学院医学研究院 精神医学) ,  OGAWA YOSHIMASA (ヤンセンファーマ) ,  HASHIMOTO SAYOKO (ヤンセンファーマ) ,  MIYAGOE HISATAKA (ヤンセンファーマ) ,  FUSHIMI FUMIHISA (ヤンセンファーマ) ,  IMAMURA KYOKO (ヤンセンファーマ)
Material： 臨床精神薬理  (Japanese Journal of Clinical Psychopharmacology)
Volume： 11  Issue： 5  Page： 929-945  Publication year： May. 10, 2008 
JST Material Number： L3883A  ISSN： 1343-3474  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： serotonin antagonist ,...
Semi thesaurus term： Acathesia ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0404248&from=J-GLOBAL&jstjournalNo=L3883A") }}

JST classification (2)： Clinical application of psychotropic drugs  (GW03110J) ,  Drug therapy(=pharmacotherapy)for mental disorders  (GR04020D)

Substance index (1)： Risperidone

Reference (5)：

• Castelão, J. F., Ferreira, L., Gelders, Y. G. et al.: The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64, 766) in the treatment of chronic psychosis. An open dose-finding study. Schizophr. Res., 2: 411-415, 1989.
• Currier, G. W., Allen, M. H.: American Association for Emergency Psychiatry survey: I. Psychiatric emergency service structure and function. Presented at the 51st Institute for Psychiatric Serivces, New Orleans, LA, USA, Oct 26-Nov 2, 1999.
• Leucht, S., Heres, S.: Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J. Clin Psychiatry, 67 (suppl. 5): 3-8, 2006.
• Leucht, S., Pitschel-Walz, G., Abraham, D. et al.: Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A metaanalysis of randomized controlled trials. Schizophr. Res., 35: 51-68, 1999.
• Schooler, N. R.: Relapse prevention and recovery in the treatment of schizophrenia. J. Clin. Psychiatry, 67 (suppl. 5): 19-23, 2006.

Terms in the title (5)： 内用液 ,  ML ,  使用成績調査 ,  安全性 ,  服薬アドヒアランス